CIOPE
Swiss trademark · 744837 · Word mark · In force
Register entry
- Registration number
- 744837
- Application number
- 04183/2020
- Status
- In force
- Type
- Word mark
- Filed
- Mar 25, 2020
- Registered
- Mar 25, 2020
- Published
- Mar 25, 2020
- Protected until
- Mar 25, 2030
- Language of procedure
- German
- Source
- Swissreg
Goods and services
Pharmaceuticals
Intravenös verabreichte pharmazeutische Erzeugnisse für den Menschen im Bereich der Onkologie ausgenommen im Bereich Augenheilkunde.
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Nov 19, 2024
Publication
Published in Swissreg on 19.11.2024
- Aug 2, 2024
Holder’s address changed
- Owner
- Sandoz AG, Lichtstrasse 35, 4056 Basel → Sandoz AG, Viaduktstrasse 3, 4051 Basel
Published in Swissreg on 02.08.2024
- Oct 24, 2023
Agent removed
- Representative
- Keller Schneider Patent- und Markenanwälte AG (Zürich), Beethovenstrasse 49, Postfach, 8027 Zürich (removed)
Published in Swissreg on 24.10.2023
- Oct 24, 2023
Transferred
- Owner
- Novartis AG, 4002 Basel → Sandoz AG, Lichtstrasse 35, 4056 Basel
Published in Swissreg on 24.10.2023
- Oct 6, 2020
Agent’s address changed
- Representative
- Schneider Feldmann AG, Patent- und Markenanwälte, Beethovenstrasse 49, Postfach, 8027 Zürich → Keller Schneider Patent- und Markenanwälte AG (Zürich), Beethovenstrasse 49, Postfach, 8027 Zürich
Published in Swissreg on 06.10.2020
- Aug 20, 2020
Partly deleted
- LGS
- 5, Pharmazeutische Erzeugnisse für den Menschen. → 5, Intravenös verabreichte pharmazeutische Erzeugnisse für den Menschen im Bereich der Onkologie ausgenommen im Bereich Augenheilkunde.
- International classification
- 5 → 5
Published in Swissreg on 20.08.2020
- Mar 25, 2020
Registered
Published in Swissreg on 25.03.2020
Parties
The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.